The Intra-Uterine Device

References

1. • Wilson JC
   A New Zealand randomized comparative study of three lUDs (Nova T®, MLCu375, MLAgCu250): 1–, 2– and 3–year results.
   Adv Contracept. 1992; 8: 153-159
   • Scopus (15)
   • PubMed
   • Crossref
   • Google Scholar
2. • World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction
   A randomized multicentre trial of the Multiload 375 and TCu380A lUDs in parous women: three-year results.
   Contraception. 1994; 49: 543-549
   • Scopus (48)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
3. • Luukkainen T
   • Allonen H
   • Kaukkamaa M
   • et al.
   Effective contraception with the levonorgestrel-releasing intrauterine device: 12–month report of a European multicenter study.
   Contraception. 1987; 36: 161-179
   • Scopus (119)
   • Abstract
   • Full Text PDF
   • Google Scholar
4. • Cole LP
   • Potts DM
   • Aranda C
   • Behliliovic B
   • Etman S
   • Moreno J
   Randic L An evaluation of the T Cu380 Ag and the Multiload Cu375.
   Fertil Steril. 1985; 43: 214-217
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
5. • Indian Council of Medical Research
   Task Force on IUD. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380 Ag, CuT 220C and CuT 220B).
   Contraception. 1989; 39: 37-52
   • Scopus (78)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
6. • Luukkainen T
   • Allonen H
   • Nielsen N-C
   • Nygren K-G
   • Pyorala T
   Five years’ experience of intrauterine contraception with the Nova-T® and the Copper-T 200.
   Am J Obstet Gynecol. 1983; 147: 885-892
   • Scopus (58)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
7. • Sastrawinata S
   • Farr G
   • Prihadi SM
   • Hutapea H
   • Anwar M
   • Wahyudi I
   • Sunjoto Kemara KP
   • Champion CB
   • Robbins M
   A comparative clinical trial of the TCu 380 Ag, Lippes Loop D, and Multiload Cu 375 lUDs in Indonesia.
   Contraception. 1991; 44: 141-154
   • Scopus (39)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
8. • Sivin I
   • Stern J
   Long-acting, more effective Copper T lUDs: a summary of US experience, 1970–75.
   Stud Fam Plann. 1979; 10: 263-281
   • PubMed
   • Crossref
   • Google Scholar
9. • Sivin I
   • Stern J
   • Diaz J
   Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380 Ag and levonorgestrel 20μg/day devices.
   Contraception. 1987; 35: 245-255
   • Scopus (67)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
10. • World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction
    The TCu 380 A IUD and the frameless IUD “the Flexigard:” interim three-year data from an international multicentre trial.
    Contraception. 1995; 52: 77-83
    • Scopus (39)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
11. • World Health Organization (WHO)
    Mechanism of action, safety and efficacy of intrauterine devices. WHO, Geneva1987 (Technical Report Series 753)
    • Google Scholar
12. • Rybo G
    • Andersson K
    IUD use and endometrial bleedings.
    in: Bardin CW Mishell Jr, DR Proceedings from the Fourth International Conference on lUDs. Butterworth-Heinemann, Boston, Mass1994: 210-218
    • Google Scholar
13. • Milšom I
    • Andersson K
    • Jonasson K
    • Linsted G
    • Rybo G
    The influence of the Gyne-T 380S® IUD on menstrual blood loss and iron status.
    Contraception. 1995; 52: 175-179
    • Scopus (62)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
14. • Burkman RT
    • the Women’s Health Study
    Association between intrauterine devices and pelvic inflammatory disease.
    Obstet Gynecol. 1981; 57: 269-276
    • PubMed
    • Google Scholar
15. • Lee NC
    • Rubin GL
    • Ory HW
    • Burkman RT
    Type of intrauterine device and the risk of pelvic inflammatory disease.
    Obstet Gynecol. 1983; 62: 1-6
    • PubMed
    • Google Scholar
16. • Kronmal RA
    • Whitney CW
    • Mumford SD
    The intrauterine device and pelvic inflammatory disease: the Women’s Health Study reanalyzed.
    J Clin Epidemiol. 1991; 44: 109-122
    • Scopus (52)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
17. • Chi l-C
    What we have learned from recent IUD studies: a researcher’s perspective.
    Contraception. 1993; 48: 81-108
    • Scopus (45)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
18. • Farley TMM
    • Rosenberg MJ
    • Rowe P
    • Chen J-H
    • Meirik O
    Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Lancet. 1992; 339: 785-788
    • Scopus (575)
    • PubMed
    • Abstract
    • Google Scholar
19. • Guillebaud J
    Contraception. Churchill Livingstone, London1993: 323-324 (Second Edition)
    • Google Scholar
20. • Population Information Program. Population Reports
    The Johns Hopkins School of Public Health, Baltimore. 1995: 22 (Volume XXII, Series B, Number 6)
    • Google Scholar
21. • UK Family Planning Research Network
    Pregnancy outcome associated with the use of lUDs.
    Br J Fam Plann. 1989; 15: 7-10
    • Google Scholar
22. • Alvior Jr, GT
    Pregnancy outcome with removal of intrauterine device.
    Obstet Gynecol. 1973; 41: 894-896
    • PubMed
    • Google Scholar
23. • Tatum HJ
    • Schmidt FH
    • Jain AK
    Management and outcome of pregnancies associated with the Copper T intrauterine devices.
    Am J Obstet Gynecol. 1976; 126: 869-879
    • Scopus (81)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
24. • Sivin I
    • El Mahgoub S
    • McCarthy T
    • Mishell DR
    • Shoupe D
    • Alvarez F
    • Brache V
    • Jimenez E
    • Diaz J
    • Faundes A
    • Diaz MM
    • Coutinho E
    • Mattos CER
    • Diaz SL
    • Pavez M
    • Stern J
    Long-term contraception with the Levonorgestrel 20 mcg/day (Lng 20) and the Copper T 380Ag intrauterine devices: a five-year randomized study.
    Contraception. 1990; 42: 361-378
    • Scopus (165)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
25. • Population Information Program. Population Reports
    The Johns Hopkins School of Public Health, Baltimore. 1995: 10 (Volume XXII, Series B, Number 6)
    • Google Scholar
26. • Guillebaud J
    Reduction by mefenamic acid of increased menstrual blood loss associated with intrauterine contraception.
    Br J Obstet Gynaecol. 1978; 85: 53-62
    • Scopus (58)
    • PubMed
    • Crossref
    • Google Scholar